Sodium fluorescein use during intraoperative cystoscopy

Obstetrics and Gynecology
Paula Jaye DoyleRonald W Wood

Abstract

Indigotindisulfonate sodium has been used during cystoscopy to identify the ureteral meatuses and to verify ureteral efflux during pelvic surgery. The U.S. Food and Drug Administration announced the shortage of indigotindisulfonate sodium in June 2014. Surgeons have since been searching for safe alternatives with comparable visualization and an economically favorable profile. The recent shortage of indigotindisulfonate sodium prompted our search for alternative options for visualizing ureteral patency during intraoperative cystoscopy. Multiple methods were considered, including instilling the bladder with D50 water, sterile water, or methylene blue-tinged saline and visualizing the contrast in either viscosity or color of the urine against the instilled medium, preoperative oral phenazopyridine, and intravenous methylene blue. Collectively, these methods proved suboptimal. As an alternative, we injected the 10% preparation of sodium fluorescein at 0.25-1 mL intravenously and observed a brilliant yellow ureteral jet minutes after injection (see Video 1). Ten percent sodium fluorescein given intravenously in doses ranging from 0.25 to 1.0 cc results in good visualization of ureteral jets. One patient experienced transient yellowi...Continue Reading

References

May 1, 1996·Urology·M Lee, R Sharifi
Dec 17, 2009·Alimentary Pharmacology & Therapeutics·M B WallaceR Kiesslich

❮ Previous
Next ❯

Citations

Feb 21, 2016·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Deepa Maheswari NarasimhuluPedram Bral
Jun 23, 2016·Journal of Minimally Invasive Gynecology·Lea Luketic, Ally Murji
Aug 16, 2016·Obstetrics and Gynecology Clinics of North America·Jenifer N Byrnes, John A Occhino
Sep 13, 2016·Urology Case Reports·Kailash KapadiaJason Kim
Nov 9, 2016·Obstetrics and Gynecology·Luis Espaillat-RijoEric A Hurtado
Aug 9, 2016·Obstetrics and Gynecology·Rebecca G Rogers, Peter C Jeppson
May 10, 2017·Obstetrics and Gynecology·Kayla E IrelandPatrick S Ramsey
Jul 22, 2017·American Journal of Obstetrics and Gynecology·Cara L GrimesJin Hee Kim
Mar 13, 2018·Obstetrics and Gynecology·Toy LeeGunhilde Buchsbaum
May 10, 2016·Obstetrics and Gynecology·Howard T Sharp, Marisa R Adelman
May 23, 2015·Obstetrics and Gynecology·Cara Grimes, Jin Hee Kim
Sep 28, 2017·International Urogynecology Journal·Yong Sun ChoiKang Sup Kim
Jan 12, 2019·Obstetrics and Gynecology·Michael L StitelyElliot MacKenzie
Dec 10, 2015·Obstetrics and Gynecology·Deepa M NarasimhuluPedram Bral
Jul 12, 2016·Obstetrics and Gynecology·Katie PropstChristine LaSala
Jan 1, 2017·International Urogynecology Journal·Saad Juma, Omer A Raheem
Nov 7, 2018·Current Opinion in Obstetrics & Gynecology·Lauren E StewartCassandra L Carberry
Jun 22, 2016·Current Opinion in Obstetrics & Gynecology·Austin D Findley, M Jonathon Solnik
Dec 21, 2018·Female Pelvic Medicine & Reconstructive Surgery·Lauren N SiffMatthew D Barber
Apr 30, 2019·Female Pelvic Medicine & Reconstructive Surgery·Tania SierraMichael K Flynn
Feb 14, 2021·International Urogynecology Journal·Sallie McSwainSteven Swift
Jul 7, 2018·Molecular Pharmaceutics·Sakkarapalayam M MahalingamPhilip S Low

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.